Rankings
▼
Calendar
IVVD
Invivyd, Inc.
$257M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$248M
Net Income
-$241M
EPS (Diluted)
$-2.17
Cash Flow
Operating Cash Flow
-$220M
Free Cash Flow
-$222M
Stock-Based Comp.
$22M
Balance Sheet
Total Assets
$383M
Total Liabilities
$27M
Stockholders' Equity
$356M
Cash & Equivalents
$92M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$248M
-$227M
-9.3%
Net Income
-$241M
-$227M
-6.4%
← Q4 2021
All Quarters
Q1 2022 →
IVVD FY 2022 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena